Starting buprenorphine at syringe service programs for opioid use
About this title
Read the official source — NCT07631598Understand this study
Who could participate?
Listed age limits: from 18 years.
What will I do during this study?
Each syringe-service programme moves from community referral to offering low-threshold buprenorphine onsite at a randomly assigned time. If you attend after your site transitions, treatment can be started through the programme with flexible procedures and peer outreach support; before transition, staff offer information and referral to community providers.
- Listed locations
- Los Angeles and 7 more locationsSee all locations and recruitment
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 512
- Sponsor
- Montefiore Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Behavioral
- Intervention type
- Behavioural, Other
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT07631598
- Official title
Show the full official title
Buprenorphine Implementation at Syringe Services Programs To Reduce Overdoses: A Type 1 Hybrid Effectiveness-Implementation Trial
Recruitment & locations
Los Angeles · Washington D.C. · Baton Rouge
5 more locations
- Duluth
- Roswell
- Grants Pass
- Greenville
- Milwaukee
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Montefiore Medical Center, a hospital or academic medical center.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
